|
1) Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007; 11: 1148-54
|
|
|
|
|
2) Shimozato S, Hiki Y, Odani H, et al. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Nephrol Dial Transplant. 2008; 6: 1931-39
|
|
|
|
|
|
3) Conley ME, Cooper MD, Michael AF, et al. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura, and systemic lupus erythematosus. J Clin Invest. 1980; 66: 1432-6
|
|
|
|
|
4) Kawamura S, Omoto K, Ueda S. Evolutionary hypervariability in the hinge region of the immunoglobulin alpha gene. J Mol Biol. 1990; 215: 201-6
|
|
|
|
|
|
5) Mattu TS, Pleass RJ, Willis AC, et al. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J Biol Chem. 1998; 273: 2260-72
|
|
|
|
|
|
6) 成松 久. ｢糖鎖｣ 研究の3大ツール. 産総研Today. 2006; 1: 18-21
|
|
|
|
|
|
7) Iwasaki H, Zhang Y, Tachibana K, et al. Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalacto-saminyltransferase 2. J Biol Chem. 2003; 278: 5613-21
|
|
|
|
|
|
8) Hiki Y, Odani H, Takahashi M, et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001; 59: 1077-85
|
|
|
|
|
|
9) Odani H, Hiki Y, Takahashi M, et al. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem Biophs Res Commun. 2000; 271: 268-74
|
|
|
|
|
|
10) Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008; 118: 629-39
|
|
|
|
|